Alumis ALMS
NASDAQ ALMS
$6.81 +0.11 (+1.64%)
At close: Oct 21, 2026 · 4:00 PM EDT

Alumis (ALMS) Net Income (2023 - 2026)

Updated

Alumis (ALMS) posted Net Income of -$142.18 million for Q2 2026, compared with $59.36 million a year earlier.

Analysis

Alumis (ALMS) Net Income (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Income at Alumis was -$286.5 million; for FY2025, it came in at -$243.29 million.

  • In prior years, Alumis' Net Income was -$294.23 million in FY2024 and -$158.17 million in FY2023.
  • The Q2 2026 figure stands as the lowest quarterly Net Income in data going back to Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 5.53 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 3.62 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.51 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -10.50 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -248.00 Mn
10 Alumis 870.27 Mn -804.57 Mn - -142.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -142.18 Mn
Dec 31, 2025 -92.93 Mn
Sep 30, 2025 -110.75 Mn
Jun 30, 2025 59.32 Mn
Mar 31, 2025 -98.96 Mn
Dec 31, 2024 -94.76 Mn
Sep 30, 2024 -93.12 Mn
Jun 30, 2024 -56.51 Mn
Mar 31, 2024 -49.85 Mn
Dec 31, 2023 -39.30 Mn
Sep 30, 2023 -43.38 Mn
Jun 30, 2023 -36.71 Mn
API Access

Alumis Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=ALMS&period=max&api_key=YOUR_API_KEY